APA (7th ed.) Citation

Suleimen Zhumatayev, Koray Yalcin, Safiye Suna Celen, Vedat Uygun, Gulsun Karasu, & Mehmet Akif Yesilipek. (2024). Blinatumomab as a Curative Therapy Option for Relapsed/Refractory Infant Acute Lymphoblastic Leukemia Post-Hematopoietic Stem Cell Transplantation - Case Report. The Korean Society of Pediatric Hematology-Oncology.

Chicago Style (17th ed.) Citation

Suleimen Zhumatayev, Koray Yalcin, Safiye Suna Celen, Vedat Uygun, Gulsun Karasu, and Mehmet Akif Yesilipek. Blinatumomab as a Curative Therapy Option for Relapsed/Refractory Infant Acute Lymphoblastic Leukemia Post-Hematopoietic Stem Cell Transplantation - Case Report. The Korean Society of Pediatric Hematology-Oncology, 2024.

MLA (9th ed.) Citation

Suleimen Zhumatayev, et al. Blinatumomab as a Curative Therapy Option for Relapsed/Refractory Infant Acute Lymphoblastic Leukemia Post-Hematopoietic Stem Cell Transplantation - Case Report. The Korean Society of Pediatric Hematology-Oncology, 2024.